Status:
COMPLETED
Role of Endorphins in the Perception of Dyspnea in Patients With Chronic Obstructive Pulmonary Disease
Lead Sponsor:
Dartmouth-Hitchcock Medical Center
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
50-90 years
Phase:
NA
Brief Summary
Endorphins are naturally occurring narcotic substances that are released when individuals perform exercise. The hypothesis of the study is that endorphins reduce the severity of breathlessness during ...
Eligibility Criteria
Inclusion
- Diagnosis of COPD
- Ability to exercise
- Ability to computer mouse to provide ratings
- \> 10 pack-years smoking
- Baseline dyspnea index \< 9
Exclusion
- Clinically significant comorbidities
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2007
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT00458419
Start Date
September 1 2005
End Date
May 1 2007
Last Update
November 2 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States, 03756-0001